JULIUS CLINICAL – SCIENCE CONTRACT RESEARCH ORGANISATION
GLOBAL & FOCUSED
Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world. Our unique combination of scientific leadership and operational excellence ensures that the trial data is of the highest quality.
We specialise in distinct therapeutic areas including Cardio Metabolic, Infectious diseases and Immunology and Brain. We can offer a full-service proposal or separate functional services as required.
ENT CLINICAL
The academic clinical research organisation with the expertise to support your clinical development program in the hearing field.
RWE & RWD
Julius Clinical’s RWE specialists and data scientists are academic thought leaders in RWE, RWD and the creation of tailor-made studies.
I/I
Julius Clinical’s experience in infectious disease research is epitomized by the CAPiTA study; the largest vaccine trial worldwide.
CARDIO METABOLIC
Julius Clinical has a strong track record of expertise and performance in the field of Cardiovascular diseases and the related field Metabolic diseases.
BRAIN
Julius Clinical is active in the field of diseases affecting the Brain, managing trials involving patients with a range of neurological or psychiatric disorders.
Only 4 hours left; our live webinar ‘𝗣𝗼𝘀𝘁-𝗹𝗶𝗰𝗲𝗻𝘀𝘂𝗿𝗲 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲: 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗮𝗻𝗱 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀.’
During this webinar, hosted by Billy Franks, Prof. Miriam Sturkenboom (UMC Utrecht, the Netherlands) will discuss:
– The need for a readily available data and analytics network in Europe for generating safety insights and conducting safety assessments post-vaccine licensure
– The conduct and findings of the IMI ADVANCE project
– Methods and sources of data for a broad EU vaccine monitoring network
– The current status of VAC4EU and future directions
Last change to register. Register: https://lnkd.in/dEfaesv